6.88
전일 마감가:
$6.52
열려 있는:
$6.57
하루 거래량:
362.29K
Relative Volume:
0.53
시가총액:
$372.15M
수익:
$2.81M
순이익/손실:
$-97.34M
주가수익비율:
-4.3544
EPS:
-1.58
순현금흐름:
$-91.47M
1주 성능:
+0.88%
1개월 성능:
-2.41%
6개월 성능:
+78.70%
1년 성능:
-21.73%
Fulcrum Therapeutics Inc Stock (FULC) Company Profile
명칭
Fulcrum Therapeutics Inc
전화
617-651-8851
주소
26 LANDSDOWNE STREET, CAMBRIDGE, MA
FULC을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
FULC
Fulcrum Therapeutics Inc
|
6.88 | 359.17M | 2.81M | -97.34M | -91.47M | -1.58 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Fulcrum Therapeutics Inc Stock (FULC) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-07-29 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2025-05-23 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
2025-05-15 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
2024-09-13 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2024-09-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2024-09-12 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
2024-09-12 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
2024-09-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
2024-09-12 | 다운그레이드 | Stifel | Buy → Hold |
2024-09-09 | 업그레이드 | BofA Securities | Underperform → Neutral |
2024-05-20 | 개시 | Cantor Fitzgerald | Overweight |
2024-03-13 | 개시 | RBC Capital Mkts | Outperform |
2023-09-25 | 개시 | Goldman | Neutral |
2023-08-23 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2023-08-22 | 업그레이드 | Stifel | Hold → Buy |
2023-05-04 | 다운그레이드 | Goldman | Buy → Neutral |
2023-03-10 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
2023-03-10 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
2023-03-09 | 다운그레이드 | Stifel | Buy → Hold |
2023-02-28 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2023-02-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2022-11-15 | 개시 | Goldman | Buy |
2022-03-08 | 개시 | Oppenheimer | Outperform |
2022-03-03 | 업그레이드 | BofA Securities | Underperform → Neutral |
2021-08-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
2021-04-26 | 재개 | Credit Suisse | Outperform |
2021-03-22 | 개시 | Credit Suisse | Outperform |
2021-03-02 | 개시 | Stifel | Buy |
2020-10-16 | 개시 | Piper Sandler | Overweight |
2020-08-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2020-08-12 | 재확인 | H.C. Wainwright | Buy |
2020-08-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2020-06-19 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
2020-06-17 | 개시 | BTIG Research | Buy |
2019-10-03 | 개시 | H.C. Wainwright | Buy |
2019-08-12 | 개시 | BofA/Merrill | Buy |
모두보기
Fulcrum Therapeutics Inc 주식(FULC)의 최신 뉴스
Full technical analysis of Fulcrum Therapeutics Inc. stockJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser
Will Fulcrum Therapeutics Inc. benefit from macro trendsWeekly Trading Summary & Verified Momentum Stock Watchlist - Newser
Will earnings trigger a reversal in Fulcrum Therapeutics Inc.2025 Sector Review & Proven Capital Preservation Methods - Newser
Analyzing Fulcrum Therapeutics Inc. with risk reward ratio chartsJuly 2025 Earnings & Reliable Momentum Entry Alerts - Newser
Building trade automation scripts for Fulcrum Therapeutics Inc.Gold Moves & AI Enhanced Trading Alerts - Newser
Analysts Apply Wyckoff Model to Fulcrum Therapeutics Inc. Stock2025 Investor Takeaways & Reliable Breakout Stock Forecasts - kangso.co.kr
How high can Fulcrum Therapeutics Inc. stock goQuarterly Profit Summary & Daily Volume Surge Signals - Newser
Risk vs reward if holding onto Fulcrum Therapeutics Inc.2025 Volatility Report & Fast Exit and Entry Trade Guides - Newser
What indicators show strength in Fulcrum Therapeutics Inc.Weekly Profit Recap & Safe Entry Trade Reports - Newser
Real time pattern detection on Fulcrum Therapeutics Inc. stockJuly 2025 Catalysts & Reliable Price Action Trade Plans - Newser
Published on: 2025-08-19 17:11:19 - Newser
Is Fulcrum Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Profit Analysis & Reliable Entry Point Trade Alerts - Newser
Applying big data sentiment scoring on Fulcrum Therapeutics Inc.Trade Risk Report & Free Expert Approved Momentum Trade Ideas - Newser
Will earnings trigger a reversal in Fulcrum Therapeutics IncSell Signal & Daily Volume Surge Trade Alerts - Newser
Will Fulcrum Therapeutics Inc. rebound enough to break evenPortfolio Growth Summary & Weekly Top Gainers Alerts - Newser
When is the best time to exit Fulcrum Therapeutics Inc.July 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - Newser
Measuring Fulcrum Therapeutics Inc.’s beta against major indicesPortfolio Gains Report & Verified Stock Trade Ideas - Newser
Using Ichimoku Cloud for Fulcrum Therapeutics Inc. technicalsPortfolio Value Summary & Low Risk Entry Point Tips - Newser
Fulcrum defended at H.C. Wainwright after data for sickle cell disease drug - MSN
Comparing Fulcrum Therapeutics Inc. in custom built stock radarsMarket Movement Recap & Long Hold Capital Preservation Plans - Newser
Is Fulcrum Therapeutics Inc. a Top Dividend Stock to Watch in 2025Stock Surge & Free High Accuracy Swing Entry Alerts - Newser
Chart overlay techniques for tracking Fulcrum Therapeutics Inc.2025 Big Picture & Free Safe Capital Growth Stock Tips - Newser
Forecasting Fulcrum Therapeutics Inc. price range with options dataTreasury Yields & Community Verified Swing Trade Signals - Newser
Quant Models Detect Momentum Reversal in Fulcrum Therapeutics Inc.2025 Trading Volume Trends & Proven Capital Preservation Methods - sundaytimes.kr
What recovery options are there for Fulcrum Therapeutics Inc.Market Growth Summary & Real-Time Volume Trigger Notifications - Newser
Will Fulcrum Therapeutics Inc. Bounce From 52 Week LowTrade Signal Summary & Free Low Drawdown Momentum Trade Ideas - classian.co.kr
XTX Topco Ltd Takes Position in Fulcrum Therapeutics, Inc. (NASDAQ:FULC) - Defense World
What makes Fulcrum Therapeutics Inc. stock price move sharplyJuly 2025 Market Mood & Risk Managed Investment Strategies - Newser
Technical signs of recovery in Fulcrum Therapeutics Inc.2025 Trading Volume Trends & Real-Time Market Trend Scan - Newser
Key External Factors That Drive Fulcrum Therapeutics Inc. Stock Price MovementsFree Entry Alert Based on Volume Spikes - Newser
Does Fulcrum Therapeutics Inc. qualify in momentum factor screeningBollinger Band Squeeze and Expansion Analysis - Newser
Fulcrum Therapeutics Inc (FULC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):